Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

imidazolyl ethanamide pentandioic acid

An orally bioavailable small molecule, with potential hematopoiesis inducing and antiviral activities. Upon oral administration, myelo001 stimulates the differentiation of bone marrow cells of the leukocytic, lymphocytic, and erythrocytic lineages, and prevents apoptosis of hematopoietic cells. This prevents chemotherapy-induced neutropenia (CIN), inhibits the risk of infections, increases tolerance and allows for the continuation of the neutropenia-inducing chemotherapeutic agent. In addition, myelo 001 has antiviral properties.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Dicarbamin
pentanedioic acid imidazolyl ethanamide
Foreign brand name:Ingavirin
Vitaglutam
Code name:Myelo 001
Myelo001
Chemical structure:6-(2-(1H-Imidazol-4-yl)ethylamino)-5-oxohexanoic acid
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search